Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Respiratory disorder? 923 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 923 reports of Respiratory disorder have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.9% of all adverse event reports for CERTOLIZUMAB PEGOL.

923
Reports of Respiratory disorder with CERTOLIZUMAB PEGOL
0.9%
of all CERTOLIZUMAB PEGOL reports
225
Deaths
303
Hospitalizations

How Dangerous Is Respiratory disorder From CERTOLIZUMAB PEGOL?

Of the 923 reports, 225 (24.4%) resulted in death, 303 (32.8%) required hospitalization, and 285 (30.9%) were considered life-threatening.

Is Respiratory disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 923 reports have been filed with the FAERS database.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615)

What Other Drugs Cause Respiratory disorder?

ADALIMUMAB (1,685) METHOTREXATE (1,335) ETANERCEPT (1,271) PREDNISONE (1,053) ABATACEPT (1,001) TOCILIZUMAB (1,000) LEFLUNOMIDE (952) GOLIMUMAB (880) ACETAMINOPHEN (869) RITUXIMAB (860)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Respiratory disorder Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Respiratory disorder Reports All Drugs Causing Respiratory disorder CERTOLIZUMAB PEGOL Demographics